SAVANNAH, Ga., Oct. 07, 2022 (GLOBE NEWSWIRE) — P23 Labs, a molecular laboratory specializing in preventative diagnostic testing, acknowledges World Mental Health Day with an awareness weekend on Oct. 8-9, aimed to foster early mental disorder detection and its efficient treatment. Both practitioners and individuals are encouraged to leverage the power of personalized medicine in mental health treatment, and the P23 team provides its input.

P23 contributes in the best viable way it can — by harnessing the Pharmacogenomics (PGx) perspective to the issue. Pharmacogenomics is the study of how people respond differently to drug therapy based on their genetic makeup or genes. 

P23 Optimum PGx is a representative of DNA testing for medication optimization. It allows healthcare providers to choose the right drug and dose that are likely to work best for each individual patient. Tailoring a patient’s medication to their unique genetic characteristics may one day replace the one-size-fits-all approach to drug selection and dosing that is commonly used today. 

The goal of Mental Health Awareness Weekend is to create a supportive environment by connecting doctors, pharmacists, and individuals with appropriate resources and information, as well as to bring attention to mental health treatment within the principles of precision medicine.

P23’s Mental…